MetaCardio ^®

MetaCardio cardiovascular and cerebrovascular metabolic function evaluation project adopts the high performance liquid chromatography tandem mass spectrometry technology platform to detect 12 markers at one time, so as to provide evaluation for 7 cardiovascular and cerebrovascular diseases and abnormal states, so as to achieve the purpose of primary prevention of cardiovascular and cerebrovascular diseases. The detection technology has the advantages of high sensitivity, strong specificity and short analysis time. MetaCardio also provides personalized health and targeted health intervention suggestions for each customer. The sampling method designed in this project is simple, and users can complete sample collection at home.

Detection Indicator

Homocysteine, betaine, choline, trimethylamine oxide, creatinine, carnitine, isoleucine, leucine, valine, phenylalanine, tyrosine, tryptophan

type of disease

Coronary heart disease, dyslipidemia, stroke, myocardial infarction, heart failure, insulin resistance, atherosclerosis

Service Process

Applicable People

• Long-term smoking and drinking
• Unbalanced diet, irregular work and rest, lack of physical activity
• Work stressful, overworked
• Immunocompromised
• "Three highs", patients with chronic or metabolic diseases
• Family history of cardiovascular and cerebrovascular